Improved renal cancer prognosis among users of drugs targeting renin-angiotensin system.

Cancer Causes Control · 2022 · PMC8776666 · PMID 34921656

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

A borderline significant risk decrease was observed also among ARB users (HR 0.91, 95% CI 0.83–1.00).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.